Germany’s CureVac jab shows only 48% effectiveness against Covid-19 in final stage of trial, driving stock plunge ...News

German biotech firm CureVac said its coronavirus vaccine showed just 48% efficacy against Covid-19 following its final analysis, marking only a slight improvement on the company’s last trial while sending its stock value tumbling. CureVac announced the second- and third-phase trial results for its CVnCoV vaccine on Wednesday, in its final analysis for a 40,000-subject study that drew participants from 10 countries across Europe and Latin America.  “In the unprecedented context of 15 strains circulating within the study population at the time of final analysis, CVnCoV demonstrated an overall vaccine efficacy of 48%... against Covid-19 d

Read More Details
Finally We wish PressBee provided you with enough information of ( Germany’s CureVac jab shows only 48% effectiveness against Covid-19 in final stage of trial, driving stock plunge )

Also on site :

• Diddy Trial Recap: Kid Cudi Testifies About Home Break-In and Porsche Molotov Cocktail Explosion
• Inside Mercedes-Benz’s plans to create a new HQ with hundreds of jobs in Atlanta
• I Write a Podcast Newsletter, and These Are My Favorite New Shows of 2025 (So Far)